X4 Pharmaceuticals (XFOR) Free Cash Flow (2017 - 2025)
X4 Pharmaceuticals posted quarterly Free Cash Flow of -$16.0 million for Q4 2025, up 51.54% year-on-year from -$10.6 million in Q4 2024, and up 42.4% on a QoQ basis from -$27.8 million in Q3 2025.
X4 Pharmaceuticals (XFOR) has 9 years of Free Cash Flow data on file, last reported at -$16.0 million in Q4 2025.
- For the quarter ending Q4 2025, Free Cash Flow rose 51.54% year-over-year to -$16.0 million; the trailing twelve-month figure through Dec 2025 stood at -$86.1 million (up 47.77% YoY), and the FY2025 full-year result was -$86.1 million, up 34.39% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$16.0 million, up from -$27.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$12.4 million in Q1 2025 and bottomed at -$68.8 million in Q3 2023.
- The 5-year median for Free Cash Flow is -$23.4 million (2022), against an average of -$28.5 million.
- The widest annual swing landed in 2023, when Free Cash Flow sank 256.33%; it then surged 63.16% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$19.1 million in 2021, then dropped by 0.32% to -$19.1 million in 2022, then plunged by 44.94% to -$27.7 million in 2023, then dropped by 19.17% to -$33.0 million in 2024, then surged by 51.54% to -$16.0 million in 2025.
- The last three Free Cash Flow figures came in at -$16.0 million (Q4 2025), -$27.8 million (Q3 2025), and -$29.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | -16.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.01 Mn |
| Dec 31, 2025 | -16.01 Mn |
| Sep 30, 2025 | -27.79 Mn |
| Sep 30, 2025 | -27.79 Mn |
| Jun 30, 2025 | -29.90 Mn |
| Jun 30, 2025 | -29.90 Mn |
| Mar 31, 2025 | -12.40 Mn |
| Mar 31, 2025 | -12.40 Mn |
| Dec 31, 2024 | -33.04 Mn |
| Dec 31, 2024 | -33.04 Mn |
| Sep 30, 2024 | -34.12 Mn |
| Sep 30, 2024 | -34.12 Mn |
| Jun 30, 2024 | -64.03 Mn |
| Jun 30, 2024 | -64.03 Mn |
| Mar 31, 2024 | -33.66 Mn |
| Mar 31, 2024 | -33.66 Mn |
| Dec 31, 2023 | -27.72 Mn |
| Dec 31, 2023 | -27.72 Mn |
| Sep 30, 2023 | -68.83 Mn |
| Sep 30, 2023 | -68.83 Mn |
| Jun 30, 2023 | -47.89 Mn |
| Jun 30, 2023 | -47.89 Mn |
| Mar 31, 2023 | -26.52 Mn |
| Mar 31, 2023 | -26.52 Mn |
| Dec 31, 2022 | -19.13 Mn |
| Dec 31, 2022 | -19.13 Mn |
| Sep 30, 2022 | -19.32 Mn |
| Sep 30, 2022 | -19.32 Mn |
| Jun 30, 2022 | -18.51 Mn |
| Jun 30, 2022 | -18.51 Mn |
| Mar 31, 2022 | -20.25 Mn |
| Mar 31, 2022 | -20.25 Mn |
| Dec 31, 2021 | -19.07 Mn |
| Dec 31, 2021 | -19.07 Mn |
| Sep 30, 2021 | -14.23 Mn |
| Sep 30, 2021 | -14.23 Mn |
| Jun 30, 2021 | -19.28 Mn |
| Jun 30, 2021 | -19.28 Mn |
| Mar 31, 2021 | -18.94 Mn |
| Mar 31, 2021 | -18.94 Mn |
| Dec 31, 2020 | -16.81 Mn |
| Dec 31, 2020 | -16.81 Mn |
| Sep 30, 2020 | -15.82 Mn |
| Sep 30, 2020 | -15.82 Mn |
| Jun 30, 2020 | -12.02 Mn |
| Jun 30, 2020 | -12.02 Mn |
| Mar 31, 2020 | -15.53 Mn |
| Mar 31, 2020 | -15.53 Mn |
| Dec 31, 2019 | -9.38 Mn |
| Dec 31, 2019 | -9.38 Mn |
| Sep 30, 2019 | -12.80 Mn |
| Sep 30, 2019 | -12.80 Mn |
| Jun 30, 2019 | -14.30 Mn |
| Jun 30, 2019 | -14.30 Mn |
| Mar 31, 2019 | -11.75 Mn |
| Mar 31, 2019 | -11.75 Mn |
| Dec 31, 2018 | -6.73 Mn |
| Dec 31, 2018 | -6.73 Mn |
| Sep 30, 2018 | -6.69 Mn |
| Sep 30, 2018 | -6.69 Mn |
| Jun 30, 2018 | -5.78 Mn |
| Jun 30, 2018 | -5.78 Mn |
| Mar 31, 2018 | -6.18 Mn |
| Mar 31, 2018 | -6.18 Mn |
| Dec 31, 2017 | -6.67 Mn |
| Dec 31, 2017 | -6.67 Mn |
| Sep 30, 2017 | -5.11 Mn |
| Sep 30, 2017 | -5.11 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Jun 30, 2017 | -6.39 Mn |
| Mar 31, 2017 | -3.53 Mn |
| Mar 31, 2017 | -3.53 Mn |